We are live on
!
Find out more
LC
Lunate Capital Portfolio holdings
AUM
$196M
1-Year Est. Return
84.21%
This Fund
S&P 500
This Quarter
Est. Return
+6.68%
1 Year Est. Return
+84.21%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$178M
AUM Growth
+$6.86M
(+4%)
Cap. Flow
+$1.01M
Cap. Flow
% of AUM
0.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Samsara
IOT
|
+$940K |
| 2 |
Revolution Medicines Inc Warrant
RVMDW
|
+$66.7K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.25% |
| 2 | Technology | 39.02% |
| 3 | Real Estate | 14.66% |
Similar funds
NWA
FCM
LWA
CCP
PAM
MAMF
DWG
CPRPA
Lunate Capital's Q2 2025 Portfolio in Review
As of Q2 2025, Lunate Capital held 6 positions worth $178M, up 4% from $171M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Lunate Capital's Q2 2025 filing shows 2 new positions. Its largest new stake was Samsara: 22,751 shares worth $905K.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Real Estate.
- Lunate Capital's largest Q2 2025 buy was Samsara: 22,751 shares worth $905K.
- Lunate Capital's ten largest holdings make up 100% of its $178M portfolio in Q2 2025.
- Lunate Capital opened 2 new positions and closed 0 in Q2 2025.
- Lunate Capital's portfolio value rose 4% quarter-over-quarter to $178M.
Based on Lunate Capital's 13F filing for Q2 2025, filed 17 Jul 2025.